Could tiny chips revolutionize cancer treatment? McGill researchers are making incredible progress.
Scientists at McGill University are developing a groundbreaking "organ chip." This technology mimics human organs to predict cancer treatment responses. It offers a potentially faster and more accurate alternative to traditional testing.
The new chip can analyze drug effectiveness on a tumor model in just days. Currently, clinical trials can take years and cost millions of dollars. Researchers believe this could significantly reduce both.
Early tests show the chip accurately predicts how patients will respond to certain therapies. Over 70% of the time, the chip's predictions aligned with actual patient outcomes. This offers hope for personalized medicine.
This innovative technology promises to accelerate cancer research and improve patient care moving forward.
